|
Information was received from a patient and manufacturing representative (rep) who was implanted with an implantable neurostimulator (ins) for unknown indications for use.It was reported that the patient's trial leads were causing extreme pain midway through the trial.Reprogramming was attempted, and impedances were low but normal.However, the patient had pain with certain electrodes being stimulated.The hcp thinks that the leads slipped off to the right gutter causing the pain even with stimulation off.The patient was taken to the er via ambulance due to severe pain, and the trial leads were removed.The issue was resolved.(b)(6) 2023 e1: the rep provided the device serial numbers.
|
|
Continuation of d10: product id 977d260 lot# serial# (b)(6) implanted: (b)(6) 2023 explanted: (b)(6) 2023 product type screening device product id 977d260 lot# serial# (b)(6) implanted: (b)(6) 2023 explanted: (b)(6) 2023 product type screening device section d information references the main component of the system.Other relevant device(s) are: product id: 977d260, serial/lot #: (b)(6), ubd: 23-feb-2027, udi#: (b)(4) ; product id: 977d260, serial/lot #: (b)(6), ubd: 15-feb-2027, udi#: (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|